Innovating Works

FINA BIOTECH

Activa
URO-BEST: UROthelial carcinoma Biomarker based diagnostic tEST FINA BIOTECH tramitó un H2020: H2020-SMEInst-2014-2015 Bladder cancer is among the five most common malignancies worldwide: more than 380.000 new cases are diagnosed yearly. If detected early, 5-...
2015-04-15 - 2015-09-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.